Induction of CYP2C12 expression in senescent male rats is well correlated to an increase of HNF3β expression, while the decline of CYP2C11 expression is unlikely due to a decrease of STAT5 activation

Biochemical Pharmacology

Volumn 73, Issue 7, 2007, Pages 923-933

  Wauthier, Valérie ^a   Dubois, Pascaline ^a   Verbeeck, Roger K ^a   Calderon, Pedro Buc ^a  

^a UNIVERSITÉ CATHOLIQUE DE LOUVAIN   (Belgium)

Author keywords

Ageing; CYP2C11; CYP2C12; Growth hormone; LETFs and STAT5b

Indexed keywords

CYTOCHROME P450 2C; CYTOCHROME P450 2C11; CYTOCHROME P450 2C12; CYTOCHROME P450 2C6; HEPATOCYTE NUCLEAR FACTOR 3BETA; ISOENZYME; MESSENGER RNA; STAT5 PROTEIN; STAT5B PROTEIN; TRANSCRIPTION FACTOR; UNCLASSIFIED DRUG;

AGED; AGING; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CORRELATION ANALYSIS; ENZYME INDUCTION; ENZYME REGULATION; FEMALE; FEMINIZATION; LIVER; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN CONTENT; PROTEIN EXPRESSION; PROTEIN FAMILY; PROTEIN PHOSPHORYLATION; RAT; SENESCENCE; SEX DIFFERENCE;

ANIMALS; ARYL HYDROCARBON HYDROXYLASES; ENZYME ACTIVATION; GENE EXPRESSION REGULATION; HEPATOCYTE NUCLEAR FACTOR 3-BETA; MALE; RATS; RATS, WISTAR; STAT5 TRANSCRIPTION FACTOR; STATISTICS; STEROID 16-ALPHA-HYDROXYLASE; STEROID HYDROXYLASES;

EID: 33847206792     PISSN: 00062952     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bcp.2006.12.003     Document Type: Article

References (48)

1. Schmucker D.L. Liver function and phase I drug metabolism in the elderly: a paradox. Drugs Aging 18 (2001) 837-851
2. Hunt C.M., Westerkam W.R., and Stave G.M. Effect of age and gender on the activity of human hepatic CYP3A. Biochem Pharmacol 44 (1992) 275-283
3. Willcox S.M., Himmelstein D.U., and Woolhandler S. Inappropriate drug prescribing for the community-dwelling elderly. J Am Med Assoc 272 (1994) 292-296
4. Schmucker D.L., and Lonergon E.T. Aging and drug disposition. Rev Biol Res Aging 3 (1987) 509-535
5. Srinivas N.R., Shyu W.C., Gleason C., Schuster A., Greene D.S., and Barbhaiya R.H. Effects of age, gender, and diurnal variation on the steady-state pharmacokinetics of BMS-181101, an antidepressant, in healthy subjects. Clin Pharmacol Ther 62 (1997) 408-416
6. Rikans L.E., and Notley B.A. Age-related changes in hepatic microsomal drug metabolism are substrate selective. J Pharmacol Exp Ther 220 (1982) 574-578
7. Rikans L.E. Hepatic drug metabolism in female Fischer rats as a function of age. Drug Metab Dispos 17 (1989) 114-116
8. Kamataki T., Maeda K., Shimada M., Kitani K., Nagai T., and Kato R. Age-related alteration in the activities of drug-metabolizing enzymes and contents of sex-specific forms of cytochrome P-450 in liver microsomes from male and female rats. J Pharmacol Exp Ther 233 (1985) 222-228
9. Imaoka S., Fujita S., and Funae Y. Age-dependent expression of cytochrome P-450s in rat liver. Biochim Biophys Acta 1097 (1991) 187-192
10. Schmucker D.L., and Wang R.K. Effects of aging and phenobarbital on the rat liver microsomal drug-metabolizing system. Mech Ageing Develop 15 (1981) 189-202
11. Warrington J.S., Court M.H., Greenblatt D.J., and von Moltke L.L. Phenacetin and chlorzoxazone biotransformation in aging male Fischer 344 rats. J Pharm Pharmacol 56 (2004) 819-825
12. Wauthier V., Verbeeck R.K., and Buc Calderon P. Age-related changes in the protein and mRNA levels of CYP2E1 and CYP3A isoforms as well as in their hepatic activities in Wistar rats. What role for oxidative stress?. Arch Toxicol 78 (2004) 131-138
13. Dhir R.N., and Shapiro B.H. Interpulse growth hormone secretion in the episodic plasma profile causes the sex reversal of cytochrome P450s in senescent male rats. Proc Natl Acad Sci USA 100 (2003) 15224-15228
14. Shapiro B.H., Agrawal A.K., and Pampori N.A. Gender differences in drug metabolism regulated by growth hormone. Int J Biochem Cell Biol 27 (1995) 9-20
15. Legraverend C., Mode A., Westin S., Strom A., Eguchi H., Zaphiropoulos P.G., et al. Transcriptional regulation of rat P-450 2C gene subfamily members by the sexually dimorphic pattern of growth hormone secretion. Mol Endocrinol 6 (1992) 259-266
16. Waxman D.J., Ram P.A., Pampori N.A., and Shapiro B.H. Growth hormone regulation of male-specific rat liver P450s 2A2 and 3A2: induction by intermittent growth hormone pulses in male but not female rats rendered growth hormone deficient by neonatal monosodium glutamate. Mol Pharmacol 48 (1995) 790-797
17. Pampori N.A., and Shapiro B.H. Gender differences in the responsiveness of the sex-dependent isoforms of hepatic P450 to the feminine plasma growth hormone profile. Endocrinology 140 (1999) 1245-1254
18. Agrawal A.K., and Shapiro B.H. Differential expression of gender-dependent hepatic isoforms of cytochrome P-450 by pulse signals in the circulating masculine episodic growth hormone profile of the rat. J Pharmacol Exp Ther 292 (2000) 228-237
19. Wiwi C.A., and Waxman D.J. Role of hepatocyte nuclear factors in growth hormone-regulated, sexually dimorphic expression of liver cytochromes P450. Growth Factor 22 (2004) 79-88
20. Choi H.K., and Waxman D.J. Growth hormone, but not prolactin, maintains, low-level activation of STAT5a and STAT5b in female rat liver. Endocrinology 140 (1999) 5126-5135
21. Choi H.K., and Waxman D.J. Plasma growth hormone pulse activation of hepatic JAK-STAT5 signaling: developmental regulation and role in male-specific liver gene expression. Endocrinology 141 (2000) 3245-3255
22. Lahuna O., Fernandez L., Karlsson H., Maiter D., Lemaigre F.P., Rousseau G.G., et al. Internalization and recycling pathways of the thyrotropin receptor. Proc Natl Acad Sci USA 94 (1997) 12309-12313
23. Endo M., Takahashi Y., Sasaki Y., Saito T., and Kamataki T. Novel gender-related regulation of CYP2C12 gene expression in rats. Mol Endocrinol 19 (2005) 1181-1190
24. Sasaki Y., Takahashi Y., Nakayama K., and Kamataki T. Cooperative regulation of CYP2C12 gene expression by STAT5 and liver-specific factors in female rats. J Biol Chem 274 (1999) 37117-37124
25. Delesque-Touchard N., Park S.H., and Waxman D.J. Synergistic action of hepatocyte nuclear factors 3 and 6 on CYP2C12 gene expression and suppression by growth hormone-activated STAT5b proposed model for female specific expression of CYP2C12 in adult rat liver. J Biol Chem 275 (2000) 34173-34182
26. Buggs C., Nasrin N., Mode A., Tollet P., Zhao H.F., Gustafsson J.A., et al. IRE-ABP (insulin response element-A binding protein), an SRY-like protein, inhibits C/EBPalpha (CCAAT/enhancer-binding protein alpha)-stimulated expression of the sex-specific cytochrome P450 2C12 gene. Mol Endocrinol 12 (1998) 1294-1309
27. Wauthier V., Schenten V., Verbeeck R.K., and Buc Calderon P. Aging is associated with increased expression but decreased activity of CYP2E1 in male Wistar rats. Life Sci 79 (2006) 1913-1920
28. Park S.H., and Waxman D.J. Inhibitory cross-talk between STAT5b and liver nuclear factor HNF3beta: impact on the regulation of growth hormone pulse-stimulated, male-specific liver cytochrome P-450 gene expression. J Biol Chem 276 (2001) 43031-43039
29. Leclercq I., Saliez A., Wallemacq P.E., Horsmans Y., and Lambotte L. The monoethylglycinexylidide test does not correctly evaluate lidocaine metabolism after ischemic liver injury in the rat. Hepatology 26 (1997) 1182-1188
30. Lowry O.H., Rosebrough N.J., Farr L., and Randall R. Protein measurement with the Folin phenol reagent. J Biol Chem 193 (1951) 265-275
31. Waxman D.J., Dannan G.A., and Guengerich F.P. Regulation of rat hepatic cytochrome P-450: age-dependent expression, hormonal imprinting, and xenobiotic inducibility of sex-specific isoenzymes. Biochemistry 24 (1985) 4409-4417
32. Kobayashi K., Urashima K., Shimada N., and Chiba K. Substrate specificity for rat cytochrome P450 (CYP) isoforms: screening with cDNA-expressed systems of the rat. Biochem Pharmacol 63 (2002) 889-896
33. Popper M. General pathology of the liver: light microscopic aspects serving diagnosis and interpretation. Semin Liver Dis 6 (1986) 175-184
34. Meihuizen S.P., and Blansjaar N. Stereological analysis of liver parenchymal cells from young and old rats. Mech Ageing Dev 13 (1980) 111-118
35. Wauthier V., Verbeeck R.K., and Buc Calderon P. Decreased CYP3A2 expression and activity in senescent male wistar rats. Is there a role for HNF-4?. Exp Gerontol 41 (2006) 846-854
36. Shapiro B.H., MacLeod J.N., Pampori N.A., and Morrissey J.J. Signalling elements in the ultradian rhythm of circulating growth hormone regulating expression of sex-dependent forms of hepatic cytochrome P450. Endocrinology 125 (1989) 2935-2944
37. Pampori N.A., and Shapiro B.H. Feminization of hepatic cytochrome P450s by nominal levels of growth hormone in the feminine plasma profile. Mol Pharmacol 50 (1996) 1148-1156
38. Agrawal A.K., and Shapiro B.H. Phenobarbital-imprinted over-induction of adult constituent CYP isoforms. Pharmacology 68 (2003) 204-215
39. Wiwi C.A., Gupte M., and Waxman D.J. Sexually dimorphic P450 gene expression in liver-specific hepatocyte nuclear factor 4alpha-deficient mice. Mol Endocrinol 18 (2004) 1975-1987
40. Lahuna O., Rastegar M., Maiter D., Thissen J.-P., Lemaigre F.P., and Rousseau G.G. Involvement of STAT5 (signal transducer and activator of transcription 5) and HNF-4 (Hepatocyte nuclear factor 4) in the transcriptional control of the hnf6 gene by growth hormone. Mol Endocrinol 14 (2000) 285-294
41. Udy G.B., Towers R.P., Snell R.G., Wilkins R.J., Park S.H., Ram P.A., et al. Requirement of STAT5b for sexual dimorphism of body growth rates and liver gene expression. Proc Natl Acad Sci USA 94 (1997) 7239-7244
42. Davey H.W., Park S.H., Grattan D.R., McLachlan M.J., and Waxman D.J. STAT5b-deficient mice are growth hormone pulse-resistant. Role of STAT5b in sex-specific liver P450 expression. J Biol Chem 274 (1999) 35331-35336
43. Park S.H., Liu X., Hennighausen L., Davey H.W., and Waxman D.J. Distinctive roles of STAT5a and STAT5b in sexual dimorphism of hepatic P450 gene expression. Impact of STAT5a gene disruption. J Biol Chem 274 (1999) 7421-7430
44. Gebert C.A., Park S.H., and Waxman D.J. Down-regulation of liver JAK2-STAT5b signaling by the female plasma pattern of continuous growth hormone stimulation. Mol Endocrinol 13 (1999) 213-227
45. Woelfe J., Billiard J., and Rotwein P. Acute control of insulin-like growth factor I gene transcription by growth hormone through STAT5b. J Biol Chem 278 (2003) 2296-2302
46. Clodfelter K.H., Holloway M.G., Hodor P., Park S.H., Ray W.J., and Waxman D.J. Sex-dependent liver gene expression is extensive and largely dependent upon STAT5b: STAT5b-dependent activation of male genes and repression of female genes revealed by microarray analysis. Mol Endocrinol 20 (2006) 1333-1351
47. Holloway M.G., Laz E.V., and Waxman D.J. Codependence of growth hormone-responsive, sexually dimorphic hepatic gene expression on signal transducer and activator of transcription 5b and hepatic nuclear factor 4alpha. Mol Endocrinol 20 (2006) 647-660
48. Verma A.S., Dhir R.N., and Shapiro B.H. Inadequacy of the Janus kinase 2/signal transducer and activator of transcription signal transduction pathway to mediate episodic growth hormone-dependent regulation of hepatic CYP2C11. Mol Pharmacol 67 (2005) 891-901